| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |